No. of Pages: 151 | Report Code: BMIRE00028313 | Category: Life Sciences
2022年亚太肺功能测试系统市场价值为5800万美元，预计到2028年将达到8740万美元；预计 2022 年至 2028 年复合年增长率为 7.1%。
家庭医疗肺功能测试系统将为亚太地区肺功能提供利润丰厚的机会未来几年功能测试系统市场的增长
大多数肺功能测试需要仅在医疗环境中可用的专用设备。然而，患有肺部疾病的患者可以使用家用肺活量计。新方法使得家庭肺活量测定可以在平板电脑或智能手机的帮助下进行。各种领先公司正在推出创新的医疗产品，特别是在患者家中进行复杂的肺部评估。此外，EasyOne Pro 通过可靠的超声技术消除校准和维护成本，提供准确的结果。肺一氧化碳弥散能力 (DLCO) 测试可以确定因呼吸系统或心脏病引起的呼吸短促，并区分哮喘和慢性阻塞性肺疾病 (COPD)，以进行适当的治疗。因此，家庭保健肺功能测试系统产品的商业化可能会在未来几年为亚太地区肺功能测试系统市场的增长提供利润丰厚的机会。
亚太地区肺功能测试系统市场概况
亚太国家肺功能测试系统市场的增长归因于人们对肺功能测试使用的认识不断增强，高度重视加强医院基础设施建设。此外，亚太地区发展中国家顶级竞争者的出现预计将推动预测期内的整体市场增长。
亚太肺功能测试系统到 2028 年的市场收入和预测（百万美元）
亚太地区肺功能测试系统市场细分
亚太地区肺功能测试系统市场根据类型、测试类型、组件、应用、最终用户和国家/地区。
根据类型，亚太地区肺功能测试系统市场分为基于推车的 PFT 系统和固定式 PFT 系统。 2022 年，基于推车的 PFT 系统细分市场在亚太肺功能测试系统市场中占据较大份额。
根据测试类型，亚太肺功能测试系统市场分为肺活量测定、肺容量、气体交换测试、最大通气量、氧滴定测试等。 2022 年，肺活量测定领域在亚太肺功能测试系统市场中占据最大份额。
根据组件，亚太肺功能测试系统市场分为硬件、软件和服务。 2022年，硬件细分市场在亚太地区肺功能测试系统市场中占据最大份额。
根据应用，亚太地区肺功能测试系统市场分为慢性阻塞性肺疾病和慢性阻塞性肺疾病。肺部疾病、哮喘、慢性呼吸短促、限制性肺病等。 2022 年，慢性阻塞性肺疾病细分市场在亚太地区肺功能测试系统市场中占据最大份额。
根据最终用户，亚太地区肺功能测试系统市场分为医院、专科诊所和诊断实验室。 2022年，医院细分市场在亚太地区肺功能检测系统市场中占据最大份额。
按国家/地区划分，亚太地区肺功能检测系统市场细分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。 2022 年，中国在亚太肺功能检测系统市场中占据主导地位。
COSMED Srl、KoKo PFT Ltd、MGC Diagnostics Corp、ndd Medical Technologies Inc、PulmOne Advanced Medical Devices Ltd、Schiller AG 和 Vyaire Medical Inc 是亚太肺功能测试系统市场的领先公司。
Strategic insights for Asia Pacific Pulmonary Function Testing Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 58.00 Million |
| Market Size by 2028 | US$ 87.40 Million |
| Global CAGR (2022 - 2028) | 7.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Pulmonary Function Testing Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Pulmonary Function Testing Systems Market is valued at US$ 58.00 Million in 2022, it is projected to reach US$ 87.40 Million by 2028.
As per our report Asia Pacific Pulmonary Function Testing Systems Market, the market size is valued at US$ 58.00 Million in 2022, projecting it to reach US$ 87.40 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.
The Asia Pacific Pulmonary Function Testing Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Pulmonary Function Testing Systems Market report:
The Asia Pacific Pulmonary Function Testing Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Pulmonary Function Testing Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Pulmonary Function Testing Systems Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Pulmonary Function Testing Systems Market
